Levulan Kerastick
Actinic Keratosis
ApprovedCommercial
Key Facts
About Sun Pharmaceutical
Founded in 1983, Sun Pharma has grown through strategic acquisitions and organic expansion to become a $4.5 billion revenue pharmaceutical giant. The company operates manufacturing facilities across India, USA, Canada, Brazil, Mexico and other countries, serving both developed and emerging markets. Sun Pharma is particularly known for its dermatology franchise and complex generics portfolio, with a growing presence in specialty therapeutics and biosimilars.
View full company profileTherapeutic Areas
Other Actinic Keratosis Drugs
| Drug | Company | Phase |
|---|---|---|
| MOB-015 (Tirbanibulin) | Mochida Pharmaceutical | Approved |
| Ameluz® | Biofrontera | Approved |
| 15dPMJ2 | Claradele Pharmaceuticals | Pre-clinical |